Khare AB - Search Results

1

Comparative tissue distribution of conformationally restricted radioiodinated vesamicol receptor ligands.

Efange SM, Khare AB, Langason RB. Efange SM, et al. Among authors: khare ab. Nucl Med Biol. 1995 May;22(4):437-44. doi: 10.1016/0969-8051(94)00135-7. Nucl Med Biol. 1995. PMID: 7550019

2

p-[18F]fluorobenzyltrozamicol ([18F]FBT): molecular decomposition- reconstitution approach to vesamicol receptor radioligands for positron emission tomography.

Efange SM, Mach RH, Khare A, Michelson RH, Nowak PA, Evora PH. Efange SM, et al. Appl Radiat Isot. 1994 Apr;45(4):465-72. doi: 10.1016/0969-8043(94)90113-9. Appl Radiat Isot. 1994. PMID: 8186771

3

Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptor.

Efange SM, Mach RH, Smith CR, Khare AB, Foulon C, Akella SK, Childers SR, Parsons SM. Efange SM, et al. Among authors: khare ab. Biochem Pharmacol. 1995 Mar 15;49(6):791-7. doi: 10.1016/0006-2952(94)00541-s. Biochem Pharmacol. 1995. PMID: 7702637

4

Spirovesamicols: conformationally restricted analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol, AH5183) as potential modulators of presynaptic cholinergic function.

Efange SM, Khare AB, Foulon C, Akella SK, Parsons SM. Efange SM, et al. Among authors: khare ab. J Med Chem. 1994 Aug 5;37(16):2574-82. doi: 10.1021/jm00042a010. J Med Chem. 1994. PMID: 8057300

5

Synthesis and tissue distribution of (m-[125I]iodobenzyl)trozamicol ([125I]MIBT): potential radioligand for mapping central cholinergic innervation.

Efange SM, Michelson RH, Khare AB, Thomas JR. Efange SM, et al. Among authors: khare ab. J Med Chem. 1993 Jun 11;36(12):1754-60. doi: 10.1021/jm00064a009. J Med Chem. 1993. PMID: 8510103

6

The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's disease.

Efange SM, Langason RB, Khare AB, Low WC. Efange SM, et al. Among authors: khare ab. Life Sci. 1996;58(16):1367-74. doi: 10.1016/0024-3205(96)00103-8. Life Sci. 1996. PMID: 8614294

7

Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding.

Efange SM, Langason RB, Khare AB. Efange SM, et al. Among authors: khare ab. J Nucl Med. 1996 Jul;37(7):1192-7. J Nucl Med. 1996. PMID: 8965197 Free article.

8

Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand.

Coffeen PR, Efange SM, Haidet GC, McKnite S, Langason RB, Khare AB, Pennington J, Lurie KG. Coffeen PR, et al. Among authors: khare ab. Nucl Med Biol. 1996 Oct;23(7):923-6. doi: 10.1016/s0969-8051(96)00132-1. Nucl Med Biol. 1996. PMID: 8971861

9

N-hydroxyalkyl derivatives of 3 beta-phenyltropane and 1-methylspiro[1H-indoline-3,4'-piperidine]: vesamicol analogues with affinity for monoamine transporters.

Efange SM, Kamath AP, Khare AB, Kung MP, Mach RH, Parsons SM. Efange SM, et al. Among authors: khare ab. J Med Chem. 1997 Nov 21;40(24):3905-14. doi: 10.1021/jm970326r. J Med Chem. 1997. PMID: 9397171

10

(+)-p-([18F]fluorobenzyl)spirotrozamicol [(+)-[18F]spiro-FBT]: synthesis and biological evaluation of a high-affinity ligand for the vesicular acetylcholine transporter (VAChT).

Efange SM, Nader MA, Ehrenkaufer RL, Khare AB, Smith CR, Morton TE, Mach RH. Efange SM, et al. Among authors: khare ab. Nucl Med Biol. 1999 Feb;26(2):189-92. doi: 10.1016/s0969-8051(98)00090-0. Nucl Med Biol. 1999. PMID: 10100218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters